drugset
drugset / Trial / NCT04688736

Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

NCT04688736 ↗

Phase 2 Recruiting 6642 enrolled Institute of Hematology & Blood Diseases Hospital, China
RandomizedParallel-groupDouble-blindPrevention

Summary

This is a prospective, randomized, double-blind controlled trial to evaluate the efficacy of placebo versus chlorpheniramine for the prevention of allergic transfusion reactions.

Timeline

Start
2021-01-01
Primary completion
2026-12-31
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorpheniramine Unknown 8 mg Oral

Indications

No indication recorded.